x

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

North America ( XML Feed )

Sep 13, 2016 2:36 EST

THORASYS Thoracic Medical Systems Inc.: We introduce fast, easy point-of-care diagnostics to pulmonary medicine and provide unique insight into critically important small airway function.

iCrowdNewswire - Sep 13, 2016

Thorasys 20logo 20600x600

THORASYS Thoracic Medical Systems Inc.

We introduce fast, easy point-of-care diagnostics to pulmonary medicine and provide unique insight into critically important small airway function.

Gust 20title

Company Summary

 

Lung diseases affect ~600M people worldwide. The total cost to the US economy exceeds $180B p.a., yet there is a profound lack of fast, easy point-of-care diagnostics. Our patented technology fills this gap, providing rapid, effortless lung function assessment and unique insights into diagnostically highly important “small airways”. Our tremoFlo C-100 AOS is approved and selling in Europe, Canada and Australia. We expect our 510(k) in early 2016.

 
  • Stage$500K in TTM Revenue
  • IndustryMedical Devices and Equipment
  • LocationMontreal, QC, Canada
  • CurrencyCAD
  • FoundedJune 2007
  • Employees4
  • Websitethorasys.com

Team

  •  dsc0462
    Founder, President & CEO

    Ph.D. in Biomedical Engineering, McGill 1997; Co-founder & President of SCIREQ Inc. 1997-2014

     

     

  • Gmaksym headshot
    Founder, Chief Scientific Advisor

    Ph.D. in Biomedical Engineering, McGill;
    Post-Doc at Harvard University;
    Professor and Director of Department of Biomedical Engineering, Dalhousie University

     

     

  • Img 4087 20 3
    Vice President, Operations & Regulatory Affairs

    M.Eng. in Engineering Management, Université de Sherbrooke;
    B.Eng. in Mechanical Engineering, École Polytechnique de Montréal

Contact Information:

Thomas Schuessler

View Related News >
support